Expression of c-fos mRNA in the basal ganglia associated with contingent tolerance to amphetamine-induced hypophagia

Behavioural Brain Research

Volumn 198, Issue 2, 2009, Pages 388-396

  Bachand, Kimberlee D ^a   Guthrie, Kathleen M ^b   Wolgin, David L ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Amphetamine; Basal ganglia; C fos; Contingent tolerance; Dorsal striatum; Response selection suppression; Stereotypy; Ventral striatum

Indexed keywords

AMPHETAMINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APPETITE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; ENTOPEDUNCULAR NUCLEUS; GENE EXPRESSION; GLOBUS PALLIDUS; HYPOPHAGIA; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; STEREOTYPY; SUBTHALAMIC NUCLEUS;

AMPHETAMINE; ANIMALS; BASAL GANGLIA; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; FEEDING BEHAVIOR; GENE EXPRESSION; GLOBUS PALLIDUS; IN SITU HYBRIDIZATION; MALE; MOTOR CORTEX; MOVEMENT; NUCLEUS ACCUMBENS; OLFACTORY PATHWAYS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SOMATOSENSORY CORTEX; STEREOTYPED BEHAVIOR; SUBTHALAMIC NUCLEUS; TIME FACTORS;

EID: 59649113957     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.11.026     Document Type: Article

References (67)

1. Allen L.F., and Winn P. Excitotoxic lesions of the pedunculopontine tegmental nucleus disinhibit orofacial behaviours stimulated by microinjections of d-amphetamine into rat ventrolateral caudate-putamen. Exp Brain Res 104 (1995) 262-274
2. Aron A.R., and Poldrack R.A. Cortical and subcortical contributions to stop signal response inhibition: role of subthalamic nucleus. J Neurosci 26 (2006) 2424-2433
3. Aron A.R., Durston S., Eagle D.M., Logan G.D., Stinear C.M., and Stuphorn V. Converging evidence for a fronto-basal-ganglia network for inhibitory control of action and cognition. J Neurosci 27 (2007) 11860-11864
4. Azrin N.H., and Peterson A.L. Treatment of Tourette syndrome by habit reversal: a waiting-list control group comparison. Behav Ther 21 (1990) 305-318
5. Bachus S.E., and Gale K. Muscimol microinfused into the nigrotegmental target area blocks selected components of behavior elicited by amphetamine or cocaine. Naunyn-Schmiedeberg's Arch Pharmacol 333 (1986) 143-148
6. Badiani A., and Robinson T.E. Drug-induced neurobehavioral plasticity: the role of environmental context. Behav Pharmacol 15 (2004) 327-339
7. Badiani A., Browman K.E., and Robinson T.E. Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine. Brain Res 674 (1995) 291-298
8. Badiani A., Anagnostaras S.G., and Robinson T.E. The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment. Psychopharmacology 117 (1995) 443-452
9. Badiani A., Oates M.M., Day H.E.W., Watson S.J., Akil H., and Robinson T.E. Amphetamine-induced behavior, dopamine release and c-fos mRNA expression: modulation by environmental novelty. J Neurosci 18 (1998) 10579-10593
10. Badiani A., Oates M.M., Day H.E.W., Watson S.J., Akil H., and Robinson T.E. Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav Brain Res 103 (1999) 203-209
11. Baker D.A., Specio S.E., Tran-Nguyen L.T.L., and Neisewander J.L. Amphetamine infused into the ventrolateral striatum produces oral stereotypies and conditioned place preference. Pharmacol Biochem Behav 61 (1998) 107-111
12. Bowen S.E., Fowler S.C., and Kallman M.J. Effects of variation in chronic dose of cocaine on contingent tolerance as assessed in a milk-drinking task. Psychopharmacology (Berl) 113 (1993) 67-75
13. Boye S.M., Grant R.J., and Clarke P.B.S. Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and d-amphetamine in rats. Neuropharmacology 40 (2001) 792-805
14. Burke K., and Lombroso P.J. Animal models of Tourette syndrome. In: Le Doux M. (Ed). Animal models of movement disorders (2005), Elsevier Academic Press, Burlington, MA 441-448
15. Canales J.J., and Graybiel A.M. A measure of striatal function predicts motor stereotypy. Nat Neurosci 3 (2000) 377-383
16. Carlton P.L., and Wolgin D. Contingent tolerance to the anorexigenic effects of amphetamine. Physiol Behav 7 (1971) 221-223
17. Childs J.A., and Gale K. Evidence that the nigrotegmental GABAergic projection mediates stereotypy induced by apomorphine and intranigral muscimol. Life Sci 33 (1983) 1007-1010
18. Costall B., Marsden C.D., Naylor R.J., and Pycock C.J. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei. Brain Res 123 (1977) 89-111
19. Creese I., and Iversen S.D. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83 (1975) 419-436
20. Curran E.J., Akil H., and Watson S.J. Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochem Res 21 (1996) 1425-1435
21. Curran T., Gordon M.B., Rubino K.L., and Sambucetti L.C. Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modification in vitro. Oncogene 2 (1987) 79-84
22. Dean P., Redgrave P., and Eastwood L. Suppression of apomorphine-induced oral stereotypy in rats by microinjection of muscimol into midbrain. Life Sci 30 (1982) 2171-2179
23. Dickson P.R., Lang C.G., Hinton S.C., and Kelley A.E. Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study. Neuroscience 61 (1994) 81-91
24. Fibiger H.C., Fibiger H.P., and Zis A.P. Attenuation of amphetamine-induced motor stimulation and stereotypy by 6-hydroxydopamine in the rat. Brit J Pharmacol 47 (1973) 683-692
25. Foltin R.W., and Schuster C.R. Behavioral tolerance and cross-tolerance to dl-cathinone and d-amphetamine in rats. J Pharmacol Exp Ther 222 (1982) 126-131
26. Graybiel A.M., Moratalla R., and Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci 87 (1990) 6912-6916
27. Guthrie K.M., Anderson A.J., Leon M., and Gall C. Odor-induced increases in c-fos mRNA expression reveal an anatomical unit for odor processing in olfactory bulb. Proc Natl Acad Sci 90 (1993) 3329-3333
28. Herrera D.G., and Robertson H.A. Activation of c-fos in the brain. Prog Neurobiol 50 (1996) 83-107
29. Heidbreder C., and Feldon J. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens. Synapse 29 (1998) 310-322
30. 2 agonists. Neuroscience 113 (2002) 939-955
31. Inglis W.L., Allen L.F., Whitelaw R.B., Latimer M.P., Brace H.M., and Winn P. An investigation into the role of the pedunculopontine tegmental nucleus in the mediation of locomotion and orofacial stereotypy induced by d-amphetamine and apomorphine in the rat. Neuroscience 58 (1994) 17-833
32. Kelly P.H., Seviour P.W., and Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94 (1975) 507-522
33. Kelley A.E. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev 27 (2004) 765-776
34. Kelley A.E., and Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 22 (2002) 3306-3311
35. Kelley A.E., Lang C.G., and Gauthier A.M. Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Psychopharmacology (Berl) 95 (1988) 556-559
36. Maurice N., Deniau J.M., Nenetrey A., Glowinski J., and Thierry A.M. Position of the ventral pallidum in the rat prefrontal cortex-basal ganglia circuit. Neuroscience 80 (1997) 523-534
37. Miller A.D., Forster G.L., Metcalf K.M., and Blaha C.D. Excitotoxic lesions of the pedunculopontine differentially mediate morphine- and d-amphetamine-evoked striatal dopamine efflux and behaviors. Neuroscience 111 (2002) 351-362
38. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 50 (1996) 381-425
39. Mink J.W. Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis. Pediat Neurol 25 (2001) 190-198
40. Mink J.W. The basal ganglia and involuntary movements. Arch Neurol 60 (2003) 1365-1368
41. Mogenson G.J. Limbic-motor integration. In: Epstein A.N. (Ed). Progress in psychobiology and physiological psychology vol. 12 (1987), Academic Press, New York 117-170
42. Mogenson G.J., Jones D.L., and Yim C.Y. From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 14 (1980) 69-97
43. Nambu A., Tokuno H., and Takada M. Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway. Neurosci Res 43 (2002) 111-117
44. Olianas M.C., DeMontis G.M., Mulas G., and Tagliamonte A. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAeric pathway. Eur J Pharm 49 (1978) 233-241
45. Piacentini J., and Chang S. Behavioral treatments for Tourette syndrome and tic disorders: state of the art. In: Cohen D.J., Goetz C.G., and Jankovic J. (Eds). Tourette syndrome (2001), Lippincott Williams and Wilkins, Philadelphia 319-331
46. Pope S.G., Dean P., and Redgrave P. Dissociation of d-amphetamine-induced locomotor activity and stereotyped behaviour by lesions of the superior colliculus. Psychopharmacology (Berl) 70 (1980) 297-302
47. Price M.T.C., and Fibiger H.C. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra. Eur J Pharmacol 29 (1974) 249-252
48. Redgrave P.R., Dean P., Donohoe T.P., and Pope S.G. Superior colliculus lesions selectively attenuate apomorphine-induced oral stereotypy: a possible role for the nigrotectal pathway. Brain Res 196 (1980) 541-546
49. Redgrave P., Prescott T.J., and Gurney K. The basal ganglia: a vertebrate solution to the selection problem?. Neuroscience 89 (1999) 1009-1023
50. Robinson T.E., Browman K.E., Crombag H.S., and Badiani A. Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration. Neurosci Biobehav Rev 22 (1998) 347-354
51. Scheel-Kruger J., and Magelund J. GABA in the entopeduncular nucleus and the subthalamic nucleus participates in mediating dopaminergic striatal output functions. Life Sci 29 (1981) 1555-1562
52. Scheel-Kruger J., Arnt J., and Magelund G. Behavioural stimulation induced by muscimol and other GABA agonists injected into the substantia nigra. Neurosci Lett 4 (1977) 351-356
53. Sellings L.H.L., and Clarke P.B.S. Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. J Neurosci 23 (2003) 6295-6303
54. Staton D.M., and Solomon P.R. Microinjections of d-amphetamine into the nucleus accumbens and caudate-putamen differentially affect stereotypy and locomotion in the rat. Physiol Psychol 12 (1984) 159-162
55. Uslaner J., Badiani A., Day H.E.W., Watson S.J., Akil H., and Robinson T.E. Environmental context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens. Brain Res 920 (2001) 106-116
56. Uslaner J., Badiani A., Norton C.S., Day H.E.W., Watson S.J., Akil H., et al. Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur J Neurosci 13 (2001) 1977-1983
57. Uslaner J., Norton C.S., Watson S.J., Akil H., and Robinson T.E. Amphetamine-induced c-fos mRNA expression in the caudate-putamen and subthalamic nucleus: interactions between dose, environment, and neuronal phenotype. J Neurochem 85 (2003) 105-114
58. Wilhelm S., Deckersbach T., Coffey B.J., Bohne A., Peterson A.L., and Baer L. Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial. Am J Psychiat 160 (2003) 1175-1177
59. Winn P., Brown V.J., and Inglis W.L. On the relationships between the striatum and the pedunculopontine tegmental nucleus. Crit Rev Neurobiol 11 (1997) 241-261
60. Wolgin D.L. Contingent tolerance to amphetamine hypophagia: new insights into the role of environmental context in the expression of stereotypy. Neurosci Biobehav Rev 24 (2000) 279-294
61. Wolgin D.L., and Hertz J.M. Effects of acute and chronic cocaine on milk intake, body weight, and activity in bottle- and cannula-fed rats. Behav Pharmacol 6 (1995) 746-753
62. Wolgin D.L., and Hughes K.M. Effect of sensitization of stereotypy on the acquisition and retention of tolerance to amphetamine hypophagia. Psychopharmacology (Berl) 126 (1996) 219-225
63. Wolgin D.L., and Kinney G.G. Effect of prior sensitization of stereotypy on the development of tolerance to amphetamine-induced hypophagia. J Pharmacol Exp Ther 262 (1992) 1232-1241
64. Wolgin D.L., and Munoz J.R. Role of instrumental learning in tolerance to cathinone hypophagia. Behav Neurosci 120 (2006) 362-370
65. Wolgin D.L., and Wade J.V. Learned suppression of stereotypy in amphetamine-treated rats: implications for understanding tolerance to amphetamine 'anorexia'. Behav Pharmacol 6 (1995) 254-262
66. Wolgin D.L., Thompson G.B., and Oslan I.A. Tolerance to amphetamine: contingent suppression of stereotypy mediates recovery of feeding. Behav Neurosci 101 (1987) 264-271
67. Zahm D.S. An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci Biobehav Rev 24 (2000) 85-105